Health Canada is providing an update on the progress of Philips Respironics’ (Philips) recall of several models of CPAP and BiLevel PAP machines and mechanical ventilators in Canada. The Department is closely monitoring the company’s progress in resolving the safety issue and implementing a repair and replacement program for affected devices in Canada. Health Canada’s safety recommendations have not changed from its July 2021 advisory.
You can report any suspected adverse reactions to drugs and other health products to the Canada Vigilance Program by visiting the Adverse Reaction and Medical Device Problem Reporting page.
Health professional or public advisories are made available on Health Canada’s Web site on an ad hoc basis as a service to health professionals, consumers, and other interested parties. These advisories may be prepared in collaboration with Directorates of Health Canada’s Health Products and Food Branch, which includes pre-market and post-market areas, as well as market authorization holders and other stakeholders.